$10.68
-1.38-11.44%
At close: -
$10.68
0.000.00%
After Hours: Apr 4, 5:32 PM EDT
Comments
Loading...
Arrowhead Pharma Earnings Estimates, EPS & Revenue | NASDAQ:ARWR | Benzinga
Arrowhead Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-1.120
Quarterly Revenue Estimate
$14.09M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$2.50M
Analyze the earnings history of Arrowhead Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARWR | Arrowhead Pharma | -$1.02 | -$1.12 | — | — | $0.00 | $14.09M | — | — | 05/08/2025 | Get Alert |
| ARWR | Arrowhead Pharma | -$1.24 | -$0.72 | -$1.39 | -93.06% | $3.55M | $19.05M | $2.50M | -86.88% | 02/10/2025 | Get Alert |
| ARWR | Arrowhead Pharma | -$1.02 | -$0.92 | -$1.37 | -48.91% | $16.10M | $58.91M | $0.00 | -100.00% | 11/26/2024 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.96 | -$0.55 | -$1.38 | -150.91% | $15.82M | $52.63M | $0.00 | -100.00% | 08/08/2024 | Get Alert |
| ARWR | Arrowhead Pharma | $0.45 | -$0.16 | -$1.02 | -537.50% | $146.27M | — | $0.00 | — | 05/09/2024 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.39 | -$0.82 | -$1.24 | -51.22% | $62.55M | $29.51M | $3.55M | -87.97% | 02/06/2024 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.81 | -$0.60 | -$1.02 | -70.00% | $31.57M | $50.73M | $16.10M | -68.27% | 11/29/2023 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.68 | -$0.58 | -$0.96 | -65.52% | $32.41M | $48.19M | $15.82M | -67.16% | 08/07/2023 | Get Alert |
| ARWR | Arrowhead Pharma | $0.41 | -$0.64 | $0.45 | 170.31% | $151.81M | $45.48M | $146.27M | 221.61% | 05/02/2023 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.60 | $0.44 | -$0.39 | -188.64% | $27.44M | $162.52M | $62.55M | -61.51% | 02/06/2023 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.61 | -$0.16 | -$0.81 | -406.25% | $38.28M | $50.44M | $31.57M | -37.40% | 11/28/2022 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.29 | -$0.51 | -$0.68 | -33.33% | $45.89M | $55.23M | $32.41M | -41.31% | 08/04/2022 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.26 | -$0.08 | $0.41 | 612.50% | $32.81M | $108.91M | $151.81M | 39.39% | 05/10/2022 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.20 | -$0.45 | -$0.60 | -33.33% | $21.30M | $51.04M | $27.44M | -46.24% | 02/02/2022 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.48 | -$0.10 | -$0.61 | -510.00% | $7.63M | $56.77M | $38.28M | -32.56% | 11/22/2021 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.13 | -$0.20 | -$0.29 | -45.00% | $27.38M | $37.52M | $45.89M | 22.31% | 08/05/2021 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.20 | -$0.13 | -$0.26 | -100.00% | $23.53M | $37.70M | $32.81M | -12.97% | 05/04/2021 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.03 | $0.17 | -$0.20 | -217.65% | $29.45M | $86.69M | $21.30M | -75.43% | 02/04/2021 | Get Alert |
| ARWR | Arrowhead Pharma | $0.11 | $0.12 | -$0.48 | -500.00% | $43.29M | $49.24M | $7.63M | -84.50% | 11/23/2020 | Get Alert |
| ARWR | Arrowhead Pharma | $0.21 | -$0.12 | -$0.13 | -8.33% | $42.70M | $28.91M | $27.38M | -5.31% | 08/05/2020 | Get Alert |
| ARWR | Arrowhead Pharma | $0.24 | -$0.11 | -$0.20 | -81.82% | $48.15M | $21.74M | $23.53M | 8.23% | 05/07/2020 | Get Alert |
Arrowhead Pharma (ARWR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-02-10 | $-1.39 | $-0.72 | -93.1 % |
| Q4 | 2024-11-26 | $-1.37 | $-0.92 | -48.9 % |
| Q3 | 2024-08-08 | $-1.38 | $-0.55 | -150.9 % |
| Q2 | 2024-05-09 | $-1.02 | $-0.16 | -537.5 % |
Arrowhead Pharma (ARWR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-02-10 | $2.50M | $19.05M | -86.9 % |
| Q4 | 2024-11-26 | $0 | $58.91M | -100.0 % |
| Q3 | 2024-08-08 | $0 | $52.63M | -100.0 % |
| Q1 | 2024-02-06 | $3.55M | $29.51M | -88.0 % |
FAQ
When is Arrowhead Pharma (NASDAQ:ARWR) reporting earnings?
Arrowhead Pharma (ARWR) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 10, 2025 for Q1.
What were the latest earnings per share (EPS) for Arrowhead Pharma (NASDAQ:ARWR)?
The Actual EPS was $-1.39, which missed the estimate of $-0.72.
What were Arrowhead Pharma’s (NASDAQ:ARWR) revenues?
The Actual Revenue was $2.5M, which missed the estimate of $19.1M.
Browse earnings estimates, EPS, and revenue on all stocks.